Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million




BRIEF-Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million


Jun 25 (Reuters) - Medexus Pharmaceuticals Q4 net income USD -2.675 million.

  • Q4 adjusted EBITDA USD 4.279 million vs. IBES estimate USD 3.47 million

Recent news on Medexus Pharmaceuticals

See all news